In Depth 21 Feb 2025 The future of organ transplants: Xenotransplantation, 3D bioprinting and stem cells …use study Another company making progress in xenotransplantation is eGenesis, with a platform that modifies the genome to reduce the molecular incompatibilities driving organ rejection and to address viral transmission… February 21, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 19 Jul 2023 Genetic engineering giants: is China poised to lead the way? …when it comes to animal genome-editing, Chinese researchers were actually the first to harness CRISPR in monkeys, and the country now has several groups of researchers conducting gene editing in… July 19, 2023 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 13 Dec 2017 CRISPR Therapeutics Plans First CRISPR/Cas9 Clinical Trial in Europe for 2018 …the first genome editing treatment of up to six that Vertex is entitled to license as per the agreement it signed with CRISPR Therapeutics back in 2015. CTX001 is what… December 13, 2017 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Opinion 25 Oct 2022 Precision medicine research must lose its Eurocentricity …in these means lower rates of diagnosis for populations that are less well represented. Why is genetics research so Eurocentric? According to one analysis of genome-wide association studies, almost three… October 25, 2022 - 7 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
More News! 30 Oct 2018 British Diagnostics Firm Develops More Accurate Fetal Health Screen …the fetal genome for genetic conditions, but can risk miscarriage. Non-invasive techniques that rely on a blood sample taken from the mother are also available. Instead of whole cells, they… October 30, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Best in Biotech 22 Feb 2024 10 gene therapy companies you should know about …the power and potential of the CRISPR/Cas12a and CRISPR/Cas9 genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. While Cas9 is… February 22, 2024 - 13 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 12 Mar 2019 Blocking Hidden Viral Protein Shows Promise for Treating Multiple Sclerosis An antibody that blocks the action of a hidden viral protein encoded by our genome shows encouraging signs of slowing down the progression of multiple sclerosis, according to the Swiss… March 12, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Podcast 5 Jan 2024 Gene editing in the microbiome could provide acne solution …package base editors that we use to not kill bacteria in the microbiome, but instead edit their genome. “So, whether it is to modify one base pair in a protein… January 5, 2024 - 6 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 28 Sep 2022 Scribe Therapeutics enters into agreement with Sanofi for use of its CRISPR technologies Scribe Therapeutics has entered into an agreement with Sanofi which will allow Sanofi use of its CRISPR genome editing technologies. Scribe Therapeutics’ custom genome editing and delivery tools called CasX-Editors… September 28, 2022 - 2 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
Best in Biotech 30 Jun 2021 Scotland’s Top 10 Biotech Companies to Watch Out For …of Dolly the sheep in 1996. To further its mission, Roslin Technologies carries out a range of services such as genome editing, genomic breeding, and biobanking. One example is supplying… June 30, 2021 - 11 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 16 Jul 2018 CRISPR-Cas9 Shown to Cause Previously Unseen DNA Damage …Published today in Nature Biotechnology, the study is the first to look at unexpected DNA changes caused by CRISPR across large regions of the genome. According to the authors, previous… July 16, 2018 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 9 Dec 2024 CAR-T cell therapy for lupus: An emerging field with great potential …lives, ranging from ibuprofen to steroid tablets and injections, or other immunosuppressant or biological medicines. A major milestone was achieved in 2011 when GSK and Human Genome Science’s belimumab was… December 9, 2024 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email